Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
RCT
ACE Report #7455
Ace Report Cover Arthroplasty

Combination of intravenous and topical TXA improves outcomes following primary TKA


Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial

J Arthroplasty. 2014 Dec;29(12):2342-6.

Contributing Authors: Z Huang J Ma B Shen F Pei

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

184 patients undergoing unilateral total knee arthroplasty (TKA) were randomized to one of two tranexamic acid groups: an intravenous administration group, or a combined topical and intravenous administration group. Patients in the intravenous group were given 3g of tranexamic acid (TXA) intravenously during surgery. Those in the combined group had a solution composed of 1.5g of TXA and 50mL of no...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.